5thPort - Crunchbase Company Profile & Funding

Q: Where is 5thPort's headquarters?

5thPort is located in Augusta, Maine, United States.

Overview

5thPort

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About 5thPort

CB Rank

770935

5thPort is a health-tech company that educates patients and caregivers.

Founded

obfuscation

Private

Augusta, Maine, United States

1-10

www.5thport.com/

Consulting

Health Care

Medical

Key People

Navroze Eduljee: Co-Founder & Chief Executive Officer
Past Role: 5thPort, Chief Information Officer
Mike Frayler: Co-Founder

Details

Legal Name

5thPort, LLC.

Operating Status

Active

Company Type

For Profit

Founders

Navroze Eduljee

Phone Number

1 888-584-7678

Contact Email

info@5thport.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

5thPort Patient Education Software

A digital platform delivering multimedia patient education, teach-back quizzes, and interactive forms to improve patient understanding and engagement before clinical visits.

5thPort eConsent Solution

A cloud-based electronic informed consent platform that enables patients to review, ask questions, and provide verifiable consent digitally, supporting remote and hybrid clinical trial settings.